Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL728201 | 0.95 | — | — | |
| SCHEMBL8227653 | 0.94 | — | — | |
| SCHEMBL13208844 | 0.94 | — | — | |
| SCHEMBL15047 | 0.94 | — | — | |
| Water SCHEMBL1245230 | 0.89 | — | — | |
| SCHEMBL7791323 | 0.89 | — | — | |
| SCHEMBL1524317 | 0.89 | — | — | |
| Iodide SCHEMBL5874467 | 0.89 | — | — | |
| SCHEMBL2035844 | 0.89 | — | — | |
| SCHEMBL4311063 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112794822-B | Cationic N-substituted aniline ionic liquid, polyionic liquid thereof, preparation method and application | 北京师范大学(CN) | 2023-01-13 | — | — | CN | claimed |
| CN-112794822-A | Cationic N-substituted aniline ionic liquid, polyionic liquid thereof, preparation method and application | 北京师范大学 | 2021-05-14 | — | — | CN | claimed |
| CN-111100070-A | Cationic N-substituted aniline ionic liquid and preparation method thereof | 北京师范大学 | 2020-05-05 | — | — | CN | claimed |
| EP-2410988-A1 | PHARMACEUTICAL COMPOSITION CONTAINING A DRUG AND SIRNA | Novartis AG (CH) | 2012-02-01 | — | — | EP | claimed |
| JP-4838514-B2 | — | — | 2011-12-14 | — | — | JP | claimed |
| WO-2011108955-A1 | MULTI -TARGETING SYSTEM COMPRISING A NANOCARRIER, NUCLEIC ACID(S) AND NON-NUCLEIC ACID BASED DRUG(S) | UNIVERSIDADE DE COIMBRA (PT) | 2011-09-09 | — | — | WO | claimed |
| WO-2010108934-A1 | PHARMACEUTICAL COMPOSITION CONTAINING A DRUG AND SIRNA | NOVARTIS AG (CH) | 2010-09-30 | — | — | WO | claimed |
| EP-2152274-A1 | NASAL ADMINISTRATION OF BENZODIAZEPINES | Questor Pharmaceuticals, Inc. (US) | 2010-02-17 | — | — | EP | claimed |
| WO-2008137960-A1 | NASAL ADMINISTRATION OF BENZODIAZEPINES | QUESTOR PHARMACEUTICALS, INC. (US) | 2008-11-13 | — | — | WO | claimed |
| EP-1658053-A2 | NOVEL COMPOSITIONS OF SILDENAFIL FREE BASE | Elan Pharma International Limited (IE) | 2006-05-24 | — | — | EP | claimed |
| EP-1613276-A1 | LOW VISCOSITY LIQUID DOSAGE FORMS | Elan Pharma International Limited (IE) | 2006-01-11 | — | — | EP | claimed |
| EP-1596830-A1 | NOVEL FLUTICASONE FORMULATIONS | Elan Pharma International Limited (IE) | 2005-11-23 | — | — | EP | claimed |
| WO-2005013937-A2 | NOVEL COMPOSITIONS OF SILDENAFIL FREE BASE | ELAN PHARMA INTERNATIONAL LTD. (IE) | 2005-02-17 | — | — | WO | claimed |
| WO-2004069225-A1 | NOVEL FLUTICASONE FORMULATIONS | ELAN PHARMA INTERNATIONAL LTD. (IE) | 2004-08-19 | — | — | WO | claimed |
| WO-2004050059-A1 | LOW VISCOSITY LIQUID DOSAGE FORMS | ELAN PHARMA INTERNATIONAL LTD. (IE) | 2004-06-17 | — | — | WO | claimed |
| US-4777297-A | ETHERIFICATION IN ALKALINE SOLUTION WITH BROMIDE OR IODIDE | MARUBISHI YUKA KOGYO KABUSHIKI KAISHA (JP) | 1988-10-11 | — | — | US | claimed |
| EP-4709842-A1 | SERUM-FREE AND XENO-FREE CULTURE MEDIUM FOR EXPANDING MESENCHYMAL STEM CELLS | Nuwacell Biotechnologies Co., Ltd. (CN) | 2026-03-18 | — | — | EP | disclosed |
| US-12507340-B2 | Resin film with conductor layer, multilayer substrate, and method for producing resin film with conductor layer | MURATA MANUFACTURING CO., LTD. (JP) | 2025-12-23 | — | — | US | disclosed |
| US-4126685-A | 6-Aryl-pyrrolo[1,2,9]imidazole derivatives which possess anti-hypertensive activity | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1978-11-21 | — | — | US | disclosed |
| US-4098621-A | Soldering fluxes | FRY'S METALS LIMITED (GB) | 1978-07-04 | — | — | US | disclosed |